Woman Man
- | Country :
- Pakistan
- | organs : -
- | Specialty : -
Extract
This observational study will evaluate the routine clinical use and the safety and efficacy of capecitabine (Xeloda®) in participants with metastatic or advanced breast cancer. Eligible participants will be followed for up to 24 months.
Inclusion criteria
- Breast Cancer